Cargando…
Primary hyperoxaluria type 1: urologic and therapeutic management
While the surgical approaches available in primary hyperoxaluria (PH) are common to all patients requiring intervention for urolithiasis, the indications for treatment and their corresponding toxicities are unique. Being a rare disease, we are guided by case series. This review summarizes the availa...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113488/ https://www.ncbi.nlm.nih.gov/pubmed/35592623 http://dx.doi.org/10.1093/ckj/sfab187 |
_version_ | 1784709593541115904 |
---|---|
author | Kohli, Harjivan Kurtz, Michael P |
author_facet | Kohli, Harjivan Kurtz, Michael P |
author_sort | Kohli, Harjivan |
collection | PubMed |
description | While the surgical approaches available in primary hyperoxaluria (PH) are common to all patients requiring intervention for urolithiasis, the indications for treatment and their corresponding toxicities are unique. Being a rare disease, we are guided by case series. This review summarizes the available literature highlighting the important disease-specific considerations. Shockwave lithotripsy (SWL) is of particular interest. It is generally the first-line treatment for stones in children, but here the stones produced will be relatively resistant to fragmentation. In addition, there are concerning reports in children of sudden unilateral decline in function in the treated kidney as measured by nuclear renography. Percutaneous nephrostolithotomy might intuitively seem favorable given the shortest drain duration and the ability to treat larger stones efficiently but, similar to SWL, rapid chronic kidney disease (CKD) progression has been seen postoperatively. Ureteroscopy is therefore generally the safest option, but considerations regarding stent encrustation, the growth of residual fragments and the large volume of stone often faced may limit this approach. The surgeon must balance the above with consideration of the patient's CKD status when considering a plan of monitoring and treating stones in PH. |
format | Online Article Text |
id | pubmed-9113488 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-91134882022-05-18 Primary hyperoxaluria type 1: urologic and therapeutic management Kohli, Harjivan Kurtz, Michael P Clin Kidney J CKJ Review While the surgical approaches available in primary hyperoxaluria (PH) are common to all patients requiring intervention for urolithiasis, the indications for treatment and their corresponding toxicities are unique. Being a rare disease, we are guided by case series. This review summarizes the available literature highlighting the important disease-specific considerations. Shockwave lithotripsy (SWL) is of particular interest. It is generally the first-line treatment for stones in children, but here the stones produced will be relatively resistant to fragmentation. In addition, there are concerning reports in children of sudden unilateral decline in function in the treated kidney as measured by nuclear renography. Percutaneous nephrostolithotomy might intuitively seem favorable given the shortest drain duration and the ability to treat larger stones efficiently but, similar to SWL, rapid chronic kidney disease (CKD) progression has been seen postoperatively. Ureteroscopy is therefore generally the safest option, but considerations regarding stent encrustation, the growth of residual fragments and the large volume of stone often faced may limit this approach. The surgeon must balance the above with consideration of the patient's CKD status when considering a plan of monitoring and treating stones in PH. Oxford University Press 2022-05-17 /pmc/articles/PMC9113488/ /pubmed/35592623 http://dx.doi.org/10.1093/ckj/sfab187 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the ERA. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | CKJ Review Kohli, Harjivan Kurtz, Michael P Primary hyperoxaluria type 1: urologic and therapeutic management |
title | Primary hyperoxaluria type 1: urologic and therapeutic management |
title_full | Primary hyperoxaluria type 1: urologic and therapeutic management |
title_fullStr | Primary hyperoxaluria type 1: urologic and therapeutic management |
title_full_unstemmed | Primary hyperoxaluria type 1: urologic and therapeutic management |
title_short | Primary hyperoxaluria type 1: urologic and therapeutic management |
title_sort | primary hyperoxaluria type 1: urologic and therapeutic management |
topic | CKJ Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113488/ https://www.ncbi.nlm.nih.gov/pubmed/35592623 http://dx.doi.org/10.1093/ckj/sfab187 |
work_keys_str_mv | AT kohliharjivan primaryhyperoxaluriatype1urologicandtherapeuticmanagement AT kurtzmichaelp primaryhyperoxaluriatype1urologicandtherapeuticmanagement |